FDA approves biosimilar to Remicade for arthritis, IBS

Stephen Feller
BETHESDA, Md., April 6 (UPI) -- Inflectra, a drug similar to Remicade, but cheaper, is expected to hit the market in 2016, helping patients with arthritis, IBS and other chronic conditions.